Olanzapine vs NK1 antagonist
Somnolence/fatigue · cancer patients
It is very uncertain whether olanzapine changes somnolence/fatigue compared with NK1 antagonist (very low certainty).
1 finding from 1 review
- Olanzapine for the prevention and treatment of cancer‐related nausea and vomiting in adults 2018 · Cochrane Headline outcomes onlyRR 1.33 [0.4, 4.49]Studies not reportedVery low